Alkermes to Participate in Two Upcoming Investor Conferences

Jefferies London Healthcare ConferenceDate/Time: Tuesday, Nov. 19, 2024 at 8:00 a.m. ET (1:00 p.m. GMT) Jefferies London Healthcare Conference Date/Time:  Tuesday, Nov. 19, 2024 at8:00 a.m. ET( 1:00 p.m. GMT ) The live webcasts may be accessed under the Investors tab onwww.alkermes.comand will be archived for 14 days. About Alkermes plc Alkermes plc is a global biopharmaceutical company that seeks to develop innovative medicines in the field of neuroscience. The company has...

DUBLIN, 11/11/2024 (informazione.it - comunicati stampa - salute e benessere)

 Tuesday, Nov. 19, 2024 at 8:00 a.m. ET ( 1:00 p.m. GMT )

The live webcasts may be accessed under the Investors tab on www.alkermes.com and will be archived for 14 days.

Alkermes plc is a global biopharmaceutical company that seeks to develop innovative medicines in the field of neuroscience. The company has a portfolio of proprietary commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of clinical and preclinical candidates in development for neurological disorders, including narcolepsy and idiopathic hypersomnia. Headquartered in Ireland , Alkermes also has a corporate office and research and development center in Massachusetts and a manufacturing facility in Ohio . For more information, please visit Alkermes' website at www.alkermes.com .

Alkermes Contact:
Jamie Constantine
Investor Relations
+1 781 873 2402

View original content: https://www.prnewswire.co.uk/news-releases/alkermes-to-participate-in-two-upcoming-investor-conferences-302301626.html